Medical Condition News

RSS

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019

Study opens a promising new front in the fight against pancreatic cancer

Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. Researchers have been searching for ways to increase the sensitivity of the tumors to cancer-fighting drugs.

19 Sep 2019

Precision grip-force test helps examine associated brain activity in people with autism

A new study in the Journal of Neurophysiology by researchers at the University of Kansas Life Span Institute is the first to look at functional brain activity in people with autism spectrum disorder (ASD) while they performed precision visuomotor behavior -- in this case, a grip-force test.

19 Sep 2019

Heart cells adjacent to injured areas respond to damage resulting from heart attack

The heart of humans and mice does not completely recover after a heart attack. It now turns out that cells close to area of the heart attack respond to the damage resulting from the heart attack, and that this response is important for survival.

19 Sep 2019

Early combination therapy provides long-term benefits for patients with type 2 diabetes

A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.

19 Sep 2019

NMDAR receptor is responsible for breast-to-brain metastases, shows study

In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.

19 Sep 2019

New device uses electromagnetic waves to reverse Alzheimer’s

A new study, to be published in the September 3, 2019, issue of the Journal of Alzheimer's Disease, provides something to cheer about for the estimated 44 million patients who have Alzheimer’s disease (AD) in the US, and their hard-pressed caregivers.

18 Sep 2019

Early life experiences underlie chronic obesity and binge-eating

A new study on the cognitive and emotional functioning of people with a high body mass index (BMI), which was published in the journal Heliyon shows that early life experiences can create a deep impact on future eating patterns and dietary habits leading to obesity or overweight.

18 Sep 2019

Zylka lab receives NIH grant to advance treatments for neurodevelopmental disorders

The National Institutes of Health have awarded two separate grants totaling $6.1 million to Mark Zylka, PhD, director of the UNC Neuroscience Center. One of the grants was co-awarded to Ben Philpot, PhD, associate director of the center at the UNC School of Medicine.

18 Sep 2019

New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

Many people in danger of the severe allergic reaction known as anaphylaxis understand exactly what they need to avoid to stay safe.

18 Sep 2019

Cannabidiol may alleviate seizures and normalize brain rhythms in Angelman syndrome

A marijuana plant extract, also known as cannabidiol, is being commonly used to improve anxiety, sleep problems, pain, and many other neurological conditions.

18 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

Psoriasis drug could be repurposed to treat osteosarcoma

A treatment for psoriasis could be repurposed to treat a rare but aggressive form of youth cancer, new findings from the Garvan Institute of Medical Research suggest.

18 Sep 2019

Compound could play a novel role in halting spread of pancreatic cancer

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

18 Sep 2019

Medical Condition News

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

Study opens a promising new front in the fight against pancreatic cancer

Precision grip-force test helps examine associated brain activity in people with autism

Heart cells adjacent to injured areas respond to damage resulting from heart attack

Early combination therapy provides long-term benefits for patients with type 2 diabetes

NMDAR receptor is responsible for breast-to-brain metastases, shows study

New device uses electromagnetic waves to reverse Alzheimer’s

Early life experiences underlie chronic obesity and binge-eating

Zylka lab receives NIH grant to advance treatments for neurodevelopmental disorders

New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

Cannabidiol may alleviate seizures and normalize brain rhythms in Angelman syndrome

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Psoriasis drug could be repurposed to treat osteosarcoma

Compound could play a novel role in halting spread of pancreatic cancer

Could drinking a small amount of alcohol everyday be good for type 2 diabetes?

Concerns over GM mosquitoes released in Brazil

Alarming number of life-threatening heart infections related to drug abuse

A vegan diet could boost gut microbes that aid weight loss

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News